.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Deloitte
Citi
Healthtrust
Daiichi Sankyo
Boehringer Ingelheim
Chubb
Farmers Insurance
AstraZeneca
Johnson and Johnson

Generated: July 25, 2017

DrugPatentWatch Database Preview

CEFPIRAMIDE SODIUM Drug Profile

« Back to Dashboard

Which patents cover Cefpiramide Sodium, and what generic Cefpiramide Sodium alternatives are available?

Cefpiramide Sodium is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in CEFPIRAMIDE SODIUM is cefpiramide sodium. There is one drug master file entry for this compound. Additional details are available on the cefpiramide sodium profile page.

Summary for Tradename: CEFPIRAMIDE SODIUM

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list27
Clinical Trials: see list2,360
Patent Applications: see list1,183
Drug Prices:see details
DailyMed Link:CEFPIRAMIDE SODIUM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst
CEFPIRAMIDE SODIUM
cefpiramide sodium
INJECTABLE;INJECTION050633-002Jan 31, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
CEFPIRAMIDE SODIUM
cefpiramide sodium
INJECTABLE;INJECTION050633-003Jan 31, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
CEFPIRAMIDE SODIUM
cefpiramide sodium
INJECTABLE;INJECTION050633-005Jan 31, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
AstraZeneca
Accenture
US Army
Cantor Fitzgerald
Johnson and Johnson
Express Scripts
Dow
Merck
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot